Advanced wound care allografts for chronic, non-healing wounds
PalinGen® Membrane and Resolve Matrix™ are designed to support clinician workflows with bioactive tissue-based solutions for wound management and tissue repair.
For healthcare professional use. Product information is not medical advice.
Product highlights
PalinGen® Membrane
- Chorion-free amniotic membrane allograft
- Processing approach intended to preserve ECM structure, growth factors, and cytokines
- Non-immunogenic profile; anti-microbial, anti-fibrotic, and anti-inflammatory properties (as described)
- Wet and dry formats in multiple sizes
- Naturally adheres to the wound surface
Resolve Matrix™
- Advanced extracellular matrix scaffold for tissue repair and regeneration
- Ready-to-use with room temperature storage
- High biocompatibility and enhanced cellular activity (as described)
- Designed to support clinician workflows
Indications
Designed for use in the management of chronic, non-healing wounds, including:
- Diabetic ulcers
- Pressure ulcers
- Venous ulcers
- Post-surgical wounds
Why LN Allog?
Quality & consistency
Focused on tissue-based solutions with clear product information and consistent availability.
Processing approach
Designed to help preserve extracellular matrix structure and key bioactive components.
Clinical & operational support
Support for product questions, ordering, and documentation needs.
Reimbursement guidance
Resources to help teams navigate coding and payer requirements.
Evidence
Review a case spotlight and supporting clinical evidence for PalinGen® Membrane, including outcomes reported with chronic wound management alongside standard care.
Reimbursement & coding (informational)
PalinGen® Membrane is assigned HCPCS code Q4173 for claims submission. Coverage and payment vary by payer and setting. Always confirm requirements with the patient’s plan and local MAC guidance.
Contact
Request product information, ordering support, or documentation.
Email: info@lnalloginc.com
Phone: 715-500-0000
Location: CA, USA